USFDA approves Taiwan's HIV drug

Drug Discovery |  News | 0 Comment | 08 Mar, 2018

A biologically-based alternative HIV treatment developed in Taiwan and manufactured in China has won approval from the U.S. Food and Drug Administration (FDA), becoming the first such made-...Read more

FDA approves Prometic’s inter-alpha-inhibitor-proteins

Drug Discovery |  News | 0 Comment | 06 Mar, 2018

Singapore-  Prometic Life Sciences Inc. announced that the U.S Food and Drug Administration (FDA) has granted a Rare Pediatric Disease Designation to its Inter-Alpha-Inhibitor-Proteins...Read more

Novo Nordisk’s diabetes pill presents the first successful data

Drug Discovery |  News | 0 Comment | 26 Feb, 2018

Novo Nordisk, the world’s largest diabetes drugmaker has presented the first successful data from a large final-stage study of a pill it hopes will transform the diabetes market. The...Read more

STA Pharma, Regulus team up for mRNA targeting drugs

Drug Discovery |  News | 0 Comment | 23 Feb, 2018

A WuXi AppTec group company, STA Pharmaceutical Co., the leading open-access capability and technology platform for small molecule pharmaceutical development and manufacturing, and Regulus ...Read more

Asia needs a legal framework to combat rare diseases

Drug Discovery |  Analysis | By Aishwarya Venkatesh | 0 Comment | 08 Feb, 2018

Orphan diseases, once rare, are now affecting larger populations, with one in every 5000 people suffering from a rare genetic disorder. The World Health Organization defines it as a disease...Read more

DL Medicine teams up with Pfizer for new drug discovery

Drug Discovery |  News | 0 Comment | 07 Feb, 2018

China based biotechnology company NetVation DL Medicine has entered into a two-year research collaboration with Pfizer Inc to produce new chemical entities against pre-selected targets from...Read more

New study shows baldness and prostate cancer may be interrelated

Drug Discovery |  News | 1 Comment | 25 Jan, 2018

Singapore - A recent study observed a connection between male-pattern baldness, when it occurs at a young age, and the subsequent development of aggressive prostate cancer.  The resear...Read more

XtalPi secures $15 M funding

Drug Discovery |  News | 0 Comment | 24 Jan, 2018

Computation-driven pharmaceutical technology company XtalPi Inc. has closed a Series B funding round of $15 million led by Sequoia China, with participation from Google and existing investo...Read more

OBI Pharma receives FDA nod for Phase I study of its cancer drug

Drug Discovery |  News | 0 Comment | 18 Jan, 2018

Taiwan-based biopharma company OBI Pharma announced that it has received the US FDA nod for an investigational new drug (IND) application for a Phase 1 study of a monoclonal antibody cancer...Read more

Forty Seven collaborates with Merck KGaA on a novel combination for ovarian cancer

Drug Discovery |  News | 0 Comment | 16 Jan, 2018

Singapore - Forty Seven, a US based clinical-stage company focused on developing the next generation of transformational immuno-oncology treatments to enable a patient's immune system to de...Read more

FDA approves first treatment for breast cancer with a certain inherited genetic mutation

Drug Discovery |  News | 0 Comment | 15 Jan, 2018

Singapore - The U.S. Food and Drug Administration expanded the approved use of Lynparza (olaparib tablets) to include the treatment of patients with certain types of breast cancer that have...Read more

Telix Pharmaceuticals establishes Japanese Subsidiary, Appoints Key Executives

Drug Discovery |  News | 0 Comment | 15 Jan, 2018

Telix Pharmaceuticals , an Australian biopharmaceutical company focused on the development of diagnostic and therapeutic products based on targeted radiopharmaceuticals or “molecularl...Read more

BerGenBio meets first efficacy endpoint in phase II trial evaluating BGB324

Drug Discovery |  News | 0 Comment | 10 Jan, 2018

A clinical –stage biopharmaceutical company BerGenBio ASA has announced that the first efficacy endpoint has been met in its phase II clinical trial evaluating BGB324 (bemcentinib) wh...Read more

Intec Pharma acknowledged with patent

Drug Discovery |  Regulatory | 0 Comment | 08 Jan, 2018

Intec Pharma is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology. The company announced that the Canadian ...Read more

Pfizer to launch a new venture fund to invest in neuroscience research projects

Drug Discovery |  News | 0 Comment | 08 Jan, 2018

The U.S. pharmaceutical company, Pfizer has announced that it is abandoning research to find new drugs aimed at treating Alzheimer’s and Parkinson’s disease. The company said t...Read more

Drug for diabetes type 2 shows potential in treating Alzheimer’s

Drug Discovery |  News | 0 Comment | 04 Jan, 2018

According to new research published in the Brain Research Journal, a drug developed for type 2 diabetes could possibly be a boon for patients with Alzheimer’s disease. The "triple ag...Read more

Biocon & Mylan's biosimilar gets Brazilian approval

Drug Discovery |  News | 0 Comment | 29 Dec, 2017

The biosimilar trastuzumab has been approved by ANVISA, the Brazilian regulatory agency. Co-developed by Biocon and Mylan, this is the first biosimilar trastuzumab to be approved in Br...Read more

FDA approves drug to treat dangerously low blood pressure

Drug Discovery |  News | 0 Comment | 27 Dec, 2017

Singapore - The U.S. Food and Drug Administration approved Giapreza (angiotensin II) injection for intravenous infusion to increase blood pressure in adults with septic or other distributiv...Read more